NCT04699123 2025-05-13
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Yale University
Phase 2 Active not recruiting
Clinical Trials
10 trialsNCT02582125 2025-03-24
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
Ono Pharmaceutical Co. Ltd
Phase 2 Completed
NCT05215067 2025-03-12
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
Akeso
Phase 2 Active not recruiting
NCT04263051 2025-02-05
Optim-UCPVax
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT06775483 2025-01-15
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Not yet recruiting
NCT05420220 2024-05-01
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Recruiting
NCT03014648 2023-12-13
Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)
University of Pittsburgh
Phase 2 Completed
NCT03693547 2023-01-10
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT02200354 2019-08-14
The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab
Kobe City General Hospital
Phase 2 Terminated
NCT00487669 2014-01-09
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
Dartmouth-Hitchcock Medical Center
Phase 2 Completed